Aker BioMarine ASA

📍 Norway🗓 Founded 2002👥 253 employees💰 Last funded Apr 2026
Biotechnology Research🌐 akerbiomarine.com
Website LinkedIn
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. We bring our nutrient-rich, all-natural krill ingredient to the pharmaceutical and nutraceutical markets through our leading brands: Superba Krill Oil, Lysoveta, Understory, and Kori Krill. Our innovative approach also extends into our spin-offs FloraMarine (plant-based source of omega-3 from algae), AION (reduce and recycle plastic waste across industries), and Understory (our protein brand). The brand results from our belief that krill is an ancient natural resource and a nutritional opportunity to improve life on our planet.  Aker BioMarine is listed on Oslo Stock Exchange (AKBM).
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2002
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Norway
1
Frequently asked questions
Who invested in Aker BioMarine ASA?
Aker BioMarine ASA has 1 investors on record on gritt.io.
When did Aker BioMarine ASA last raise funding?
The most recent investment in Aker BioMarine ASA recorded on gritt.io was in April 2026.
When was Aker BioMarine ASA founded?
Aker BioMarine ASA was founded in 2002.
What industry is Aker BioMarine ASA in?
Aker BioMarine ASA operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aker BioMarine ASA based?
Aker BioMarine ASA is headquartered in Norway.